Prospective, Randomized, Double-blind, Placebo-controlled Clinical Study of the Safety and Efficacy of the Vaccine for the Prevention of Pentavalent Live Rotavirus Infection in Healthy Subjects (Target Age of 18-45 Years Old).
Latest Information Update: 15 Sep 2021
At a glance
- Drugs Bovine rotavirus vaccine reassortant (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Pharm Aid
- 15 Sep 2021 New trial record